1. Aldana PC., Khachemoune A. Grover disease: review of subtypes with a focus on management options. International Journal of Dermatology. Blackwell Publishing Ltd; 2020. pp. 543–550.
2. Bellinato F., Maurelli M., Gisondi P., Girolomoni G. Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review. JDDG - Journal of the German Society of Dermatology. Wiley-VCH Verlag; 2020. pp. 826–833.
3. Lacarruba F., Boscaglia S., Nasca MR., Caltabiano R., Micali G. Grover’s disease: dermoscopy, reflectance confocal microscopy and histopathological correlation. Dermatology Practical & Conceptual. Mattioli1885; 2017; 7(3): 51–54.
4. Nedelcu R., Dobre A., Turcu G., Andrei R., Balasescu E., Pantelimon F., et al. Grover’s Disease Association with Cutaneous Keratinocyte Cancers: More than a Coincidence? International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute (MDPI); 2024.
5. Gantz M., Butler D., Goldberg M., Ryu J., McCalmont T., Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: A systematic review. Journal of the American Academy of Dermatology. Mosby Inc.; 2017. pp. 952-957.e1.
6. Simpson CL., Tiwaa A., Zaver SA., Johnson CJ., Chu EY., Harms PW., et al. ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology. 2024; DOI:10.1172/jci
7. Awe O., Pavlidakey P., Kole L., Kissel R. Drug-induced Grover’s disease: a case report and review of the literature. International Journal of Dermatology. John Wiley and Sons Inc; 2022; 61(5): 591–594. DOI:10.1111/ijd.15803
8. Seli D., Ellis KT., Goldust M., Shah K., Hu R., Zhou J., et al. Association of Somatic ATP2A2 Damaging Variants with Grover Disease. JAMA Dermatology. American Medical Association; 2023; 159(7): 745–749. DOI:10.1001/jamadermatol.2023.1139
9. Gupta N., Virgen CA., Goyal A., Lane AA., Antin JH., Divito SJ., et al. Novel use of acitretin for posttransplant Grover’s disease and cutaneous graft versus host disease. JAAD Case Reports. Elsevier Inc, 2023; 33: 67–69. DOI:10.1016/j.jdcr.2023.01.011
10. Moodie D., Dunn C., Fernandez C., Nathoo R. Retinoids for the Treatment of Refractory Grover’s Disease: A Case Series and Review of the Literature. Cureus. Springer Science and Business Media LLC; 2024; DOI:10.7759/cureus.53510
11. Kaprive JF., Washburn S., Emerson CM., Mullins T. Successful treatment of resistant Grover’s disease with dupilumab. International Journal of Women’s Dermatology. Wolters Kluwer Medknow Publications; 2024; 10(2): E140. DOI:10.1097/JW9.0000000000000140
12. Olagbenro M., Ravi S., Myers D., Lin D., Woodburn W., Walter JR., et al. Assessment of Blue Light Phototherapy for Grover Disease: A Nonrandomized Controlled Trial. JAMA Dermatology. American Medical Association; 2023; 159(1): 102–104. DOI:10.1001/jamadermatol.2022.4491
13. Renz P, Hasan S, English JC, Wegner RE, Jedrych J, Ho J, Colonias A. Grover’s Disease Treated With Total Skin Electron Beam Radiotherapy. J Drugs Dermatol. 2019;18(4):392-393.
14. Pendlebury GA., Oro P., Merideth D., Rudnick E. A rare case of transient acantholytic dermatosis (Aka. grover’s disease) with concomitant pediculosis pubis: An atypical presentation and first documented case report. Dermatopathology. Multidisciplinary Digital Publishing Institute (MDPI); 2021; 8(4): 502–508. DOI:10.3390/dermatopathology8040052
15. Sousou JM, Fritsche JM, Fernandez BR, Tummala MR, Scott R. Management and Treatment of Grover's Disease: A Case Report and Review of Literature. Cureus. 2022 Apr 12;14(4):e24082. doi: 10.7759/cureus.24082
16. Zabawski EJ. Transient Acantholytic Dermatosis (Grover Disease) Treatment & Management. Medscape, 2024. https://emedicine.medscape.com/article/1124347-treatment#d1